VentriPoint Diagnostics Ltd.
VPTDF
$0.08
$0.00-3.22%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.29M | -2.90M | -3.27M | -3.38M | -3.59M |
| Total Depreciation and Amortization | 43.80K | 43.70K | 43.90K | 44.40K | 45.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 356.90K | 632.10K | 948.40K | 688.60K | 566.00K |
| Change in Net Operating Assets | 776.10K | 1.03M | 647.10K | 603.30K | 508.00K |
| Cash from Operations | -1.11M | -1.20M | -1.64M | -2.04M | -2.47M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 1.32M | 1.03M | 1.34M | 2.36M | 1.68M |
| Total Debt Repaid | -121.20K | -120.30K | -119.40K | -118.50K | -157.60K |
| Issuance of Common Stock | 474.90K | 944.00K | 1.21M | 864.60K | 857.30K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -136.00K | -204.00K | -211.70K | -271.10K | -174.60K |
| Cash from Financing | 1.09M | 1.17M | 1.58M | 2.04M | 1.60M |
| Foreign Exchange rate Adjustments | 12.30K | -12.20K | 1.80K | -23.40K | -34.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.90K | -38.40K | -50.30K | -25.90K | -911.30K |